These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 14479334)

  • 1. The determination of copper in biological materials by flame spectrophotometry.
    NEWMAN GE; RYAN M
    J Clin Pathol; 1962 Mar; 15(2):181-4. PubMed ID: 14479334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
    Walshe JM
    QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary copper excretion before and after oral intake of d-penicillamine in parents of patients with Wilson's disease.
    Vieira J; Oliveira PV; Juliano Y; Warde KR; Deguti MM; Barbosa ER; Carrilho FJ; Cancado EL
    Dig Liver Dis; 2012 Apr; 44(4):323-7. PubMed ID: 22169274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Checking of urinary copper in patients with Wilson's disease during treatment with D-penicillamine].
    Indaco A; Pellegrino L; Campanella G
    Acta Neurol Quad (Napoli); 1979; 39():160-4. PubMed ID: 555232
    [No Abstract]   [Full Text] [Related]  

  • 5. Copper content of hair and nails in Wilson's disease (hepatolenticular degeneration).
    RICE EW; GOLDSTEIN NP
    Metabolism; 1961 Dec; 10():1085-7. PubMed ID: 14491888
    [No Abstract]   [Full Text] [Related]  

  • 6. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives.
    Prasad R; Kaur G; Walia BN
    Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
    Marecek Z; Heyrovský A; Volek V
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wilson's disease: assessment of D-penicillamine treatment.
    Van Caillie-Bertrand M; Degenhart HJ; Luijendijk I; Bouquet J; Sinaasappel M
    Arch Dis Child; 1985 Jul; 60(7):652-5. PubMed ID: 4026361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The urinary excretion of radiocopper in presymptomatic and symptomatic Wilson's disease, heterozygotes and controls: its significance in diagnosis and management.
    Gibbs K; Hanka R; Walshe JM
    Q J Med; 1978 Jul; 47(187):349-64. PubMed ID: 715173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary copper excretion and hepatic copper concentrations in liver disease.
    Frommer DJ
    Digestion; 1981; 21(4):169-78. PubMed ID: 7215719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The copper content of some organs in Wilson's disease].
    PLOOIJ M; van der MEER ; KAAG A
    Ned Tijdschr Geneeskd; 1960 Feb; 104():324-6. PubMed ID: 14433511
    [No Abstract]   [Full Text] [Related]  

  • 12. BASAL COPPER EXCRETION IN WILSON'S DISEASE.
    WARREN CB; BROUGHTON PM
    Arch Dis Child; 1964 Jun; 39(205):265-7. PubMed ID: 14169457
    [No Abstract]   [Full Text] [Related]  

  • 13. Excretion of copper in sweat of patients with Wilson's disease during sauna bathing.
    Sunderman FW; Hohnadel DC; Evenson MA; Wannamaker BB; Dahl DS
    Ann Clin Lab Sci; 1974; 4(5):407-12. PubMed ID: 4851957
    [No Abstract]   [Full Text] [Related]  

  • 14. Practical recommendations and new therapies for Wilson's disease.
    Brewer GJ
    Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stimulated urinary copper excretion in the diagnosis of Wilson's disease].
    López-Sanromán A; Foruny JR; Camarero C; Boixeda D
    Gastroenterol Hepatol; 2015; 38(7):467. PubMed ID: 25619901
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pathogenesis and treatment of Wilson's disease].
    Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
    Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Copper levels in the tissues of patients with Wilson's disease].
    Petrovecki V; Kovacić Z; Pizent A; Jakić-Razumović J
    Arh Hig Rada Toksikol; 1997 Jun; 48(2):241-6. PubMed ID: 9471969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COPPER BALANCE STUDIES IN WILSON'S DISEASE (HEPATOLENTICULAR DEGENERATION). OBSERVATIONS ON THE EFFECT OF PENICILLAMINE, CARBO-RESIN AND POTASSIUM SULFIDE.
    GOLDSTEIN NP; RANDALL RV; GROSS JB; MCGUCKIN WF
    Trans Am Neurol Assoc; 1963; 88():221-2. PubMed ID: 14272232
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of the combined administration of glutathione and D-penicillamine on the urinary copper excretion in Wilson's disease].
    Atsuba Y; Nakahachi T; Terai T; Kozakai T
    No To Shinkei; 1968 Feb; 20(2):187-95. PubMed ID: 5695072
    [No Abstract]   [Full Text] [Related]  

  • 20. [Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine].
    Lange J; Brandt G
    Med Welt; 1981 Jan; 32(3):109-10. PubMed ID: 7207132
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.